× |
|
Coping With Craving and Withdrawal Due to Substance Use Disorders During the COVID-19 Lockdown PDF |
$40.00 |
|
$40.00 |
× |
|
Etizolam Use Disorder and Withdrawal in a Patient in Sustained Remission From Opioid, Cocaine, and Methamphetamine Use Disorders PDF |
$40.00 |
|
$40.00 |
× |
|
Moderators and Mediators of Symptoms and Quality of Life Outcomes in an Open-Label Study of Adults Treated for Attention-Deficit/Hyperactivity Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies PDF |
$40.00 |
|
$40.00 |
× |
|
A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder PDF |
$40.00 |
|
$40.00 |
× |
|
Impact of Psychiatric Comorbidity and Cognitive Deficit on Function in 22q11.2 Deletion Syndrome PDF |
$40.00 |
|
$40.00 |
× |
|
Magnitude and Correlates of Symptomatic, Global Illness, and Social Functioning Response; Out-of-Home Placement; and Length of Stay in 1,189 Consecutively Hospitalized Children and Adolescents With Mental Disorders PDF |
$40.00 |
|
$40.00 |
× |
|
Randomized Controlled Trials of Psychoeducation Modalities in the Management of Bipolar Disorder: A Systematic Review PDF |
$40.00 |
|
$40.00 |
× |
|
Is Age-at-Onset Criterion Relevant for the Response to Methylphenidate in Attention-Deficit/Hyperactivity Disorder? PDF |
$40.00 |
|
$40.00 |
× |
|
QT Interval Duration and Dispersion in Children and Adolescents Treated With Ziprasidone PDF |
$40.00 |
|
$40.00 |
|